Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 1—January 2012


Accelerating Control of Pertussis in England and Wales

Helen CampbellComments to Author , Gayatri Amirthalingam, Nick Andrews, Norman K. Fry, Robert C. George, Timothy Harrison, and Elizabeth Miller
Author affiliations: Health Protection Agency, London, UK

Main Article

Figure 1

Figure 1. Changes to routine childhood pertussis immunization programs and notifications of pertussis disease (all ages) and vaccine coverage among children <2 years of age, England and Wales, 1940–2009. DTwP, diphtheria/tetanus/whole-cell pertussis vaccine; DTaP3, diphtheria/tetanus/3-component acellular pertussis vaccine; DTaP5, diphtheria/tetanus/5-component aP vaccine; DTaP3-Hib, diphtheria/tetanus/3-component acellular pertussis/Haemophilus influenzae type b vaccine; DTaP3-Hib-IPV, diphtheria/tetanus/3-component acellular pertussis/Haemophilus influenzae type b/inactivated polio vaccine; DTaP3-IPV, diphtheria/tetanus/3-component acellular pertussis/inactivated polio vaccine; DTaP5-IPV, diphtheria/tetanus/5-component acellular pertussis/inactivated polio vaccine.

Main Article